We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 10,000 results
  1. Mechanistic insights on TLR-4 mediated inflammatory pathway in neurodegenerative diseases

    Neurodegenerative diseases (NDDs) pose a significant issue in healthcare, needing a thorough knowledge of their complex molecular mechanisms. A...

    Veerta Sharma, Prateek Sharma, Thakur Gurjeet Singh in Pharmacological Reports
    Article 25 June 2024
  2. A derivative of 3-(1,3-diarylallylidene)oxindoles inhibits dextran sulfate sodium-induced colitis in mice

    Background

    IA-0130 is a derivative of 3-(1,3-diarylallylidene)oxindoles, which is a selective estrogen receptor modulator (SERM). A previous study...

    Young-** Jeong, Hae-Ri Lee, ... Tae-Hwe Heo in Pharmacological Reports
    Article Open access 25 June 2024
  3. Investigation of the Antinociceptive and Gastroprotective Potential of the Flavonoid Tricin and its Possible Mechanism of Action

    Tricin is a flavonoid that occurs in monocotyledonous plants and exhibits a broad pharmacological spectrum, including anti-inflammatory and...

    José Jailson Lima Bezerra, Alisson Macário de Oliveira, Antônio Fernando Morais de Oliveira in Revista Brasileira de Farmacognosia
    Article 24 June 2024
  4. Qualitative Analysis of Inquiries Received by FDA Regarding Conduct of Clinical Trials during the Covid-19 Public Health Emergency

    Background

    This report describes the U.S. Food and Drug Administration (FDA) experience in establishing a dedicated mailbox, and in publishing related...

    Marijo Kambere, Hong Vu, ... John Concato in Therapeutic Innovation & Regulatory Science
    Article Open access 24 June 2024
  5. Multi-layered metabolic effects of trehalose on the liver proteome in apoE-knockout mice model of liver steatosis

    Background

    Metabolic dysfunction-associated fatty liver disease has been well documented as a key independent risk factor for the development of...

    Weronika Pogoda, Jakub Koczur, ... Maciej Suski in Pharmacological Reports
    Article Open access 24 June 2024
  6. Use of Seamless Study Designs in Oncology Clinical Development– A Survey Conducted by IDSWG Oncology Sub-team

    Seamless study designs have the potential to accelerate clinical development. The use of innovative seamless designs has been increasing in the...

    Yingwen Dong, Gautier Paux, ... Philip He in Therapeutic Innovation & Regulatory Science
    Article 22 June 2024
  7. Patient and Public Perceptions in Canada About Decentralized and Hybrid Clinical Trials: “It’s About Time we Bring Trials to People”

    Background

    Little is known about patient and the public perspectives on decentralized and hybrid clinical trials in Canada.

    Methods

    We conducted an...

    Dawn P. Richards, John Queenan, ... Susan Marlin in Therapeutic Innovation & Regulatory Science
    Article Open access 21 June 2024
  8. Luteolin for neurodegenerative diseases: a review

    Neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, and multiple sclerosis affect millions of people...

    Dunuvilla Kavindi Jayawickreme, Cletus Ekwosi, ... Katarzyna Socała in Pharmacological Reports
    Article Open access 21 June 2024
  9. The effect of phencyclidine-mediated blockade of NMDA receptors in the early postnatal period on glutathione and sulfur amino acid levels in the rat brain as a potential causative factor of schizophrenia-like behavior in adulthood

    Background

    Phencyclidine, an NMDA receptor antagonist, is frequently used to model behavioral and neurochemical changes correlated with schizophrenia...

    Elżbieta Lorenc-Koci, Magdalena Górny, ... Zofia Rogóż in Pharmacological Reports
    Article Open access 21 June 2024
  10. β-Carboline derivatives are potent against Acute Myeloid Leukemia in vitro and in vivo

    Background

    β -carboline alkaloids exert a distinguished ability to impair cell growth and induce cell death in a variety of cancers and the evaluation...

    Maura Lima Pereira Bueno, Mary Ann Foglio, ... Fernanda Marconi Roversi in Pharmacological Reports
    Article 20 June 2024
  11. Harmonizing Quality Improvement Metrics Across Global Trial Networks to Advance Paediatric Clinical Trials Delivery

    Background

    Despite global efforts to improve paediatric clinical trials, significant delays continue in paediatric drug approvals. Collaboration...

    Sabah Attar, Angie Price, ... Ricardo M. Fernandes in Therapeutic Innovation & Regulatory Science
    Article Open access 20 June 2024
  12. Challenges and opportunities of develo** small-molecule therapies for age-related macular degeneration

    Age-related macular degeneration (AMD) is the leading cause of vision loss in senior adults. The disease can be categorized into two types: wet AMD...

    **ang Fei, Sooyun Jung, ... Seung-Yong Seo in Archives of Pharmacal Research
    Article 20 June 2024
  13. Zuranolone in postpartum depression: a profile of its use in the USA

    Zuranolone (ZURZUVAE ® ), an orally bioavailable neuroactive steroid and a selective, positive, allosteric modulator of both synaptic and extrasynaptic...

    Hannah A. Blair in Drugs & Therapy Perspectives
    Article 19 June 2024
  14. The role of glucagon-like peptide-1/GLP-1R and autophagy in diabetic cardiovascular disease

    Diabetes leads to a significantly accelerated incidence of various related macrovascular complications, including peripheral vascular disease and...

    Article 19 June 2024
  15. In vitro biological evaluation of a novel folic acid-targeted receptor quantum dot−β−cyclodextrin carrier for C−2028 unsymmetrical bisacridine in the treatment of human lung and prostate cancers

    Background

    Traditional small-molecule chemotherapeutics usually do not distinguish tumors from healthy tissues. However, nanotechnology creates...

    Joanna Pilch, Agnieszka Potęga, ... Anna Maria Nowicka in Pharmacological Reports
    Article Open access 18 June 2024
  16. Add or switch to systemics and biologics where topical paediatric hidradenitis suppurativa therapy fails

    Hidradenitis suppurativa (HS) is a debilitating chronic inflammatory skin condition that typically develops in adults but can rarely affect...

    Caroline Fenton, Connie Kang in Drugs & Therapy Perspectives
    Article 18 June 2024
  17. Overdosage Section in US and EU Labeling

    The Prescribing Information (PI) in the United States (US) and the Summary of Product Characteristics (SmPC) in the European Union (EU) are approved...

    Sarah Condon, Thomas G. Cantu, ... Joanna Szewczyk in Therapeutic Innovation & Regulatory Science
    Article Open access 17 June 2024
  18. The effect of new atypical antipsychotic drugs on the expression of transcription factors regulating cytochrome P450 enzymes in rat liver

    Background

    Our recent studies showed that prolonged administration of novel atypical antipsychotics affected the expression and activity of cytochrome...

    Przemysław J. Danek, Władysława A. Daniel in Pharmacological Reports
    Article Open access 15 June 2024
  19. Anti-elastase, Anti-tyrosinase, and Anti-inflammatory Activities of Three Compounds Isolated from Psorospermum aurantiacum: In Silico and In Vitro Assays

    The hexane fraction of Psorospermum aurantiacum Engl., Hypericaceae, was found to prevent photo aging in skin cells lines. Therefore, this research...

    Jacqueline N. Manjia, Emmanuel Mfotie Njoya, ... Paul F. Moundipa in Revista Brasileira de Farmacognosia
    Article 15 June 2024
Did you find what you were looking for? Share feedback.